SERD Market is Predicted to Exhibit Remarkable Growth Owing to the Usage of Faslodex in Combination, Strong Performance of ORSERDU, and Speedy Progress of Other Oral SERDs, During the Study Period (2020–2034) | DelveInsight
October 02, 2024 13:00 ET
|
DelveInsight Business Research LLP
New York, USA, Oct. 02, 2024 (GLOBE NEWSWIRE) -- SERD Market is Predicted to Exhibit Remarkable Growth Owing to the Usage of Faslodex in Combination, Strong Performance of ORSERDU, and Speedy...
Breast Cancer Clinical Trial Pipeline Appears Robust With 100+ Key Pharma Companies Actively Working in the Therapeutics Segment | DelveInsight
October 01, 2024 13:00 ET
|
DelveInsight Business Research LLP
New York, USA, Oct. 01, 2024 (GLOBE NEWSWIRE) -- Breast Cancer Clinical Trial Pipeline Appears Robust With 100+ Key Pharma Companies Actively Working in the Therapeutics Segment | DelveInsight ...
KRAS Inhibitors Market: New Treatments Are Set to Change Cancer Care | DelveInsight
September 30, 2024 13:00 ET
|
DelveInsight Business Research LLP
New York, USA, Sept. 30, 2024 (GLOBE NEWSWIRE) -- KRAS Inhibitors Market: New Treatments Are Set to Change Cancer Care | DelveInsight According to DelveInsight’s analysis, the growth of the KRAS...
Global Nicotine Replacement Therapy Market is Predicted to Exhibit Remarkable Growth at a CAGR of ~7% by 2030 | DelveInsight
September 26, 2024 13:00 ET
|
DelveInsight Business Research LLP
New York, USA, Sept. 26, 2024 (GLOBE NEWSWIRE) -- Global Nicotine Replacement Therapy Market is Predicted to Exhibit Remarkable Growth at a CAGR of ~7% by 2030 | DelveInsight The nicotine...
Sarcopenia Market Anticipates Impressive Growth Trajectory Across 7MM During the Study Period (2020–2034) | DelveInsight
September 25, 2024 13:00 ET
|
DelveInsight Business Research LLP
New York, USA, Sept. 25, 2024 (GLOBE NEWSWIRE) -- Sarcopenia Market Anticipates Impressive Growth Trajectory Across 7MM During the Study Period (2020–2034) | DelveInsight The sarcopenia market...
Renal Cancer Clinical Trial Pipeline Appears Robust With 75+ Key Pharma Companies Actively Working in the Therapeutics Segment | DelveInsight
September 24, 2024 13:00 ET
|
DelveInsight Business Research LLP
New York, USA, Sept. 24, 2024 (GLOBE NEWSWIRE) -- Renal Cancer Clinical Trial Pipeline Appears Robust With 75+ Key Pharma Companies Actively Working in the Therapeutics Segment | DelveInsight ...
Cyclo-oxygenase 2 Inhibitors Clinical Trial Pipeline Experiences Momentum: DelveInsight Estimates a Diverse Pipeline Comprising 20+ Companies Working in the Domain
September 23, 2024 11:30 ET
|
DelveInsight Business Research LLP
New York, USA, Sept. 23, 2024 (GLOBE NEWSWIRE) -- Cyclo-oxygenase 2 Inhibitors Clinical Trial Pipeline Experiences Momentum: DelveInsight Estimates a Diverse Pipeline Comprising 20+ Companies...
Global Corporate Wellness Market to Surpass ~USD 117 Billion by 2030 | DelveInsight
September 23, 2024 06:30 ET
|
DelveInsight Business Research LLP
New York, USA, Sept. 23, 2024 (GLOBE NEWSWIRE) -- Global Corporate Wellness Market to Surpass ~USD 117 Billion by 2030 | DelveInsight The growing demand for corporate wellness is largely driven...
Graft versus Host Disease Market to Increase at a CAGR of 9.9% During the Study Period (2020–2034) | DelveInsight
September 22, 2024 00:30 ET
|
DelveInsight Business Research LLP
New York, USA, Sept. 22, 2024 (GLOBE NEWSWIRE) -- Graft versus Host Disease Market to Increase at a CAGR of 9.9% During the Study Period (2020–2034) | DelveInsight The graft versus host disease...
Squamous Cell Carcinoma Clinical Trial Pipeline Insights: 75+ Key Companies Investigating Their Lead Candidates to Improve the Treatment Space | DelveInsight
September 20, 2024 13:00 ET
|
DelveInsight Business Research LLP
New York, USA, Sept. 20, 2024 (GLOBE NEWSWIRE) -- Squamous Cell Carcinoma Clinical Trial Pipeline Insights: 75+ Key Companies Investigating Their Lead Candidates to Improve the Treatment Space |...